期刊
JOURNAL OF DIABETES RESEARCH
卷 2016, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2016/1379274
关键词
-
资金
- Japan Society for the Promotion of Science [26461230]
- Japan Health Foundation
- MSD
- Novartis
- Takeda
- Otsuka
- Kyowa Kirin
- Eli Lilly
- Chugai
- Mitsubishi Tanabe
- Kissei
- Torii
- Astellus
- Bayer
- Boehringer Ingelheim
- Grants-in-Aid for Scientific Research [26461230] Funding Source: KAKEN
Diabetic vascular complications are the most common cause of mortality and morbidity worldwide, with numbers of affected individuals steadily increasing. Diabetic vascular complications can be divided into two categories: macrovascular and microvascular complications. Macrovascular complications include coronary artery disease and cerebrovascular disease, while microvascular complications include retinopathy and chronic kidney disease. These complications result from metabolic abnormalities, including hyperglycemia, elevated levels of free fatty acids, and insulin resistance. Multiple mechanisms have been proposed to mediate the adverse effects of these metabolic disorders on vascular tissues, including stimulation of protein kinase C signaling and activation of the polyol pathway by oxidative stress and inflammation. Additionally, the loss of tissue-specific insulin signaling induced by hyperglycemia and toxic metabolites can induce cellular dysfunction and both macro-and microvascular complications characteristic of diabetes. Despite these insights, few therapeutic methods are available for the management of diabetic complications. Recently, incretin-based therapeutic agents, such as glucagon-like peptide-1 and dipeptidyl peptidase-4 inhibitors, have been reported to elicit vasotropic actions, suggesting a potential for effecting an actual reduction in diabetic vascular complications. The present review will summarize the relationship between multiple adverse biological mechanisms in diabetes and putative incretin-based therapeutic interventions intended to prevent diabetic vascular complications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据